Table S2 from Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery

Liu, Hui; Liu, Kangdong; Dong, Zigang

doi:10.1158/0008-5472.22427502.v1

00085472can202245-sup-246580_2_supp_6545811_qg2dht.pdf (406.92 kB)

Table S2 from Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery

journal contribution

posted on 2023-03-31, 04:06 authored by Hui Liu, Kangdong Liu, Zigang Dong

Inhibitors of CDKs

History

ARTICLE ABSTRACT

Cyclin-dependent kinase 12 (CDK12) is a member of the CDK family of proteins (CDK) and is critical for cancer development. Years of study into CDK12 have generated much information regarding the intricacy of its function and mechanism as well as inhibitors against it for oncological research. However, there remains a lack of understanding regarding the role of CDK12 in carcinogenesis and cancer prevention. An exhaustive comprehension of CDK12 will highly stimulate the development of new strategies for treating and preventing cancer. Here, we review the literature of CDK12, with a focus on its function, its role in signaling, and how to use it as a target for discovery of novel drugs for cancer prevention and therapy.